To realize President Biden's goal of eradicating cancer, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs.
Sequence data on more than 800 farm or wastewater Enterobacteriaceae isolates suggested pangenome dynamics may be influenced by geography and environmental niches.
With gut microbiome data for individuals sampled four years apart, researchers saw stable and unstable gut microbial species, including those linked to host phenotypes.
Researchers said that the score further may identify patients whose treatment resistance may be overcome with combination strategies targeting certain cells.
The program is part of a 10-year initiative focused on establishing the frameworks and infrastructure to roll out precision medicine throughout the country.
As a new clinical affiliate, Invitae will test up to 25,000 patients in a study exploring the role of genetics in cancer, heart disease, and other conditions.
Hologic intends to invest in assay development for Mobidiag's Novodiag PCR platform, which provides high-level multiplexing to detect infectious disease organisms.
The reissuance will continue the initiative's focus on proteogenomic research and applying proteogenomics to understanding cancer drug response and resistance.
CA Healthcare Acquisition, a special purpose acquisition company, said the transaction will support the development of LumiraDx’s pipeline of more than 30 assays.
The company's test uses self-collected saliva samples from potential parents to assess their future child's genetic predisposition to various diseases.
Using genome, exome, or transcriptome sequences from dozens of uterine leiomyosarcoma samples, researchers found alterations that may respond to existing targetable treatments.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
